Past Events

This online SPARK Europe Webinar by Kristian Lund will reveal why the Clinical Evaluation Plan (CEP) and Clinical Evaluation Report (CER) are not just paperwork — they are the foundation of your MDR/IVDR market approval.

In this SPARK-BIH National Gene and Cell Therapies Webinar, Dr. Sarah Weschke will share insights on how the early incorporation of patients’ expertise and experiences in research enhances relevance and patient-centeredness, ultimately fostering the successful translation of findings into clinical practice.

Join this online SPARK Europe Webinar with Barbara Diehl, Peter Mumford and Julia Wagner in unpacking how to navigate risk assessment and make confident, informed decisions about turning academic science into a viable commercial venture.

In this SPARK-BIH National Gene and Cell Therapies Webinar, Dr. Melissa van Pel will share her knowledge on process development, clinical manufacture and testing strategies for Cell Therapies.

In this SPARK-BIH National Gene and Cell Therapies Webinar, Dr. Barbara Volz and Dr. Michael Moles will share their knowledge about the European ATMP regulatory landscape, the challenges developers face, and global initiatives fostering ATMP development.

In this online SPARK Europe Webinar Dale Mitchell and Sarah Gould will share their insights on how early-stage academic projects and startups may benefit from working with CRO’s.

Join our SPARK-BIH Webinar with VC experts to prepare yourself for future interactions and learn what you need to know to convince VCs and secure your next funding round.

In this SPARK-BIH National Gene and Cell Therapies Webinar, Dr. Stefanie Grunwald (Berlin Institute of Health) will unlock strategic insights into the IP landscape shaping the future of gene and cell therapies.

In this SPARK Europe Webinar, Andrew Wright (Partner and Patent Attorney at Potter Clarkson) will introduce the concept of crafting an IP roadmap that aligns with your business plan.

In this SPARK Europe Webinar, Suzanne Einmahl (Ph.D. in Pharmaceutical Sciences) will explore the latest regulatory guidelines, challenges, and best practices in the development and approval of cell and gene therapies.